Forte Biosciences, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Forte Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
  • Forte Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$12.5M, a 40.6% decline year-over-year.
  • Forte Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$35.8M, a 49.5% decline year-over-year.
  • Forte Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$31.5M, a 127% decline from 2022.
  • Forte Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.9M, a 36.1% increase from 2021.
  • Forte Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$21.7M, a 53.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$31.5M -$17.6M -127% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$13.9M +$7.83M +36.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$21.7M +$24.8M +53.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$46.5M -$42.4M -1042% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$4.07M +$44.9M +91.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$49M -$10M -25.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$38.9M -$5.45M -16.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$33.5M -$10.4M -45.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$23.1M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.